157 related articles for article (PubMed ID: 32710919)
1. Boosting drug bioavailability in men but not women through the action of an excipient.
Mai Y; Ashiru-Oredope DAI; Yao Z; Dou L; Madla CM; Taherali F; Murdan S; Basit AW
Int J Pharm; 2020 Sep; 587():119678. PubMed ID: 32710919
[TBL] [Abstract][Full Text] [Related]
2. An animal's sex influences the effects of the excipient PEG 400 on the intestinal P-gp protein and mRNA levels, which has implications for oral drug absorption.
Mai Y; Dou L; Murdan S; Basit AW
Eur J Pharm Sci; 2018 Jul; 120():53-60. PubMed ID: 29678614
[TBL] [Abstract][Full Text] [Related]
3. Excipient-mediated alteration in drug bioavailability in the rat depends on the sex of the animal.
Mai Y; Afonso-Pereira F; Murdan S; Basit AW
Eur J Pharm Sci; 2017 Sep; 107():249-255. PubMed ID: 28709912
[TBL] [Abstract][Full Text] [Related]
4. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
[TBL] [Abstract][Full Text] [Related]
5. Sex-Dependence in the Effect of Pharmaceutical Excipients: Polyoxyethylated Solubilising Excipients Increase Oral Drug Bioavailability in Male but not Female Rats.
Mai Y; Dou L; Madla CM; Murdan S; Basit AW
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31083453
[TBL] [Abstract][Full Text] [Related]
6. Establishing an in vitro permeation model to predict the in vivo sex-related influence of PEG 400 on oral drug absorption.
Mai Y; Murdan S; Awadi M; Basit AW
Int J Pharm; 2018 May; 542(1-2):280-287. PubMed ID: 29530563
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific effects of excipients on oral drug bioavailability.
Mai Y; Madla CM; Shao H; Qin Y; Merchant HA; Murdan S; Basit AW
Int J Pharm; 2022 Dec; 629():122365. PubMed ID: 36336203
[TBL] [Abstract][Full Text] [Related]
8. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.
Shen Q; Lin Y; Handa T; Doi M; Sugie M; Wakayama K; Okada N; Fujita T; Yamamoto A
Int J Pharm; 2006 Apr; 313(1-2):49-56. PubMed ID: 16500056
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in excipient effects: Enhancement in ranitidine bioavailability in the presence of polyethylene glycol in male, but not female, rats.
Afonso-Pereira F; Murdan S; Sousa J; Veiga F; Basit AW
Int J Pharm; 2016 Jun; 506(1-2):237-41. PubMed ID: 27085641
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability.
Nguyen TT; Duong VA; Maeng HJ
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371794
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females.
Ashiru DA; Patel R; Basit AW
Pharm Res; 2008 Oct; 25(10):2327-33. PubMed ID: 18600434
[TBL] [Abstract][Full Text] [Related]
12. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.
Hugger ED; Novak BL; Burton PS; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1991-2002. PubMed ID: 12210046
[TBL] [Abstract][Full Text] [Related]
13. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
15. Excipient effects on gastrointestinal transit and drug absorption in beagle dogs.
Schulze JD; Peters EE; Vickers AW; Staton JS; Coffin MD; Parsons GE; Basit AW
Int J Pharm; 2005 Aug; 300(1-2):67-75. PubMed ID: 15979264
[TBL] [Abstract][Full Text] [Related]
16. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.
Lin Y; Shen Q; Katsumi H; Okada N; Fujita T; Jiang X; Yamamoto A
Biol Pharm Bull; 2007 Jul; 30(7):1301-7. PubMed ID: 17603171
[TBL] [Abstract][Full Text] [Related]
17. [Advances in the study of excipient inhibitors of intestinal P-glycoprotein].
Yan F; Si LQ; Huang JG; Li G
Yao Xue Xue Bao; 2008 Nov; 43(11):1071-6. PubMed ID: 19239022
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro.
Gurjar R; Chan CYS; Curley P; Sharp J; Chiong J; Rannard S; Siccardi M; Owen A
Mol Pharm; 2018 Nov; 15(11):4835-4842. PubMed ID: 30350641
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
[TBL] [Abstract][Full Text] [Related]
20. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion.
Li M; Si L; Pan H; Rabba AK; Yan F; Qiu J; Li G
Int J Pharm; 2011 Jan; 403(1-2):37-45. PubMed ID: 20969937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
